Results 221 to 230 of about 16,534,485 (359)

Report of 18th Session of the CLIVAR Scientific Steering Group - SSG18. 02-05 May 2011, Intergovernmental Oceanographic Commission (IOC), Paris, France

, 2011
International CLIVAR Project Office
core  

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Risk network analysis and simulation research in municipal engineering projects contracted by China in Saudi Arabia. [PDF]

Sci Rep
Alotaibi RTT.
europepmc   +1 more source

Report of the Thirteenth Session of the JSC/CLIVAR Working Group on Coupled Modelling (WGCM), 28-30 September 2009, San Francisco, USA [PDF]

, 2010
International CLIVAR Project Office
core  

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

The efficacy and safety of lower-dose aspirin for primary and secondary prevention of cardiovascular disease in the elderly: an interim analysis of a multicenter, prospective, observational study. [PDF]

Front Cardiovasc Med
Wang X, Qi H, Wu Y, Cong H, Hao P, Liu X, Liu Y, Yao Z, Jin A, Hou Y, He N, Zhao Y, Sun Y, Qian X, Liang K, Zhang H, Liu L, Zhang Z, Liu Y, Dou P, Xia S, Li H, Yang J, Hu J, Xia Z, Liu B, Jin H, Yan X, Miao W, Guo H, Zhao L, Zhang Q, Tian T, Sun X, He J, Chen X, Wang Z, Zhang Z, Liu Q, Wang J, Zhu S, Liu M.   +41 more
europepmc   +1 more source

Other-projected environmental image: A conceptual framework

, 2014
Ji Li
openalex   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

The ART of evidence-based care: proof of concept of a novel strategy to accelerate research translation in health organisations. [PDF]

Front Health Serv
Harding KE, Lewis AK, Considine J, Casey P, Davis ID, Dennett A, Tan G, Boyle JA, Taylor NF.   +8 more
europepmc   +1 more source

$sup 235$U--THORIUM FUEL CYCLES IN GRAPHITE MODERATED SYSTEMS. Project DRAGON.

, 1965
J. Blomstrand, J. Schlosser, H. Bruneder, U. Nyffenegger, G. Graziani   +4 more
openalex   +1 more source